Only a certain amount of venting is allowed here a
Post# of 148190
Price drop today is an overreaction IMO. Unless the vaccine is available to every American in the next few weeks (it'll be a year or more until it's that *widely* available) then it doesn't change the landscape all that much for Leronlimab at all.
If folks don't want to wait for CD12, they can sell and buy back when they think the time is right. Risky though. I prefer adding to the pile and sitting on long-term shares.